Related case:
NADAP 2020 Alwyn Cassar vs ADC - Appeal
February 8, 2021
In Mei 2019 the National Anti-Doping Commission (ADC) has reported an anti-doping rule violation against the powerlifter Alwyn Cassar after he tested positive for the prohibited substance Testosterone.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the National Anti-Doping Disciplinary Panel.
The Athlete accepted the test result and denied the intentional use of the substance. He explained with evidence that the Testosterone was used as prescribed medication by his doctor. Previously the Athlete made an application for a retroactive TUE which was denied in June 2019 and again in October 2019 following his appeal.
The Panel finds that the presence of the prohibited substance had been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. Considering the Athlete's request the Panel concludes that there are no grounds not to disclose the Athlete's identity.
The Disciplinairy Panel accepts that the prescribed Testosterone was used for a legitimate medical treatment because of the Athlete's condition. However the Panel deems that the Athlete and his doctor failed in their responsibility to apply in advance for a TUE.
Therefore the National Anti-Doping Disciplinary Panel decides on 24 November 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 5 June 2019.
